Clinical-stage biotech Recursion Pharmaceuticals ' (NASDAQ: RXRX) stock took it on the chin in the first trading day of the week. Monday saw investors back out of the company's shares, leaving them ...

The idea of prehistory still seduces the artworld with its glinting, uncontroversial promise of a shared origin. Can it mean ...